FISH to visualize genetic abnormalities characteristic of pancreatic cancer

Dr. Gordon DeWald, professor emeritus in laboratory medicine and laboratory genetics at Mayo Clinic, provides an overview of his study on the use of fluorescence in situ hybridization (FISH) to visualize genetic abnormalities characteristic of pancreatic cancer. Article available at: http://tinyurl.com/cwbzue8

Related Videos